ERC1
Basic information
Region (hg38): 12:990509-1495933
Previous symbols: [ "RAB6IP2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ERC1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 41 | 49 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 1 | |||||
Total | 0 | 1 | 42 | 6 | 9 |
Variants in ERC1
This is a list of pathogenic ClinVar variants found in the ERC1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-1027920-G-A | not specified | Uncertain significance (May 31, 2023) | ||
12-1027951-G-C | ERC1-related disorder | Benign (Jun 17, 2019) | ||
12-1027967-C-T | not specified | Uncertain significance (Feb 12, 2024) | ||
12-1027988-C-T | not specified | Uncertain significance (Sep 22, 2023) | ||
12-1028028-C-T | not specified | Uncertain significance (Dec 07, 2021) | ||
12-1028051-A-G | ERC1-related disorder | Benign (May 28, 2019) | ||
12-1028163-G-T | not specified | Uncertain significance (Jan 03, 2024) | ||
12-1028200-T-G | ERC1-related disorder | Likely benign (Nov 01, 2021) | ||
12-1028203-C-T | ERC1-related disorder | Likely benign (Feb 22, 2019) | ||
12-1028211-G-A | not specified | Uncertain significance (Mar 30, 2024) | ||
12-1028211-G-C | ERC1-related disorder | Likely benign (Dec 28, 2022) | ||
12-1028226-G-A | not specified | Uncertain significance (Jan 07, 2022) | ||
12-1028267-A-G | not specified | Uncertain significance (Sep 06, 2022) | ||
12-1028423-G-A | not specified | Uncertain significance (Jan 24, 2023) | ||
12-1028450-A-G | not specified | Uncertain significance (Jul 09, 2021) | ||
12-1028498-G-A | not specified | Uncertain significance (May 02, 2024) | ||
12-1083303-T-A | not specified | Uncertain significance (Apr 25, 2023) | ||
12-1083447-G-A | not specified | Uncertain significance (Apr 20, 2024) | ||
12-1083520-C-T | ERC1-related disorder | Likely benign (Feb 25, 2019) | ||
12-1083521-G-A | not specified | Uncertain significance (Jun 07, 2023) | ||
12-1104760-G-A | not specified | Uncertain significance (Jan 31, 2024) | ||
12-1104765-T-G | not specified | Uncertain significance (Mar 01, 2023) | ||
12-1110205-C-G | not specified | Uncertain significance (Oct 21, 2021) | ||
12-1110209-T-A | ERC1-related disorder | Benign (Dec 31, 2019) | ||
12-1110274-G-A | not specified | Uncertain significance (Oct 26, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ERC1 | protein_coding | protein_coding | ENST00000397203 | 18 | 505425 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.06e-7 | 1.00 | 125692 | 0 | 56 | 125748 | 0.000223 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.45 | 510 | 611 | 0.834 | 0.0000344 | 7407 |
Missense in Polyphen | 230 | 294.15 | 0.78192 | 3537 | ||
Synonymous | -1.34 | 246 | 221 | 1.11 | 0.0000117 | 2048 |
Loss of Function | 4.43 | 23 | 60.0 | 0.383 | 0.00000353 | 691 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000243 | 0.000242 |
Ashkenazi Jewish | 0.000298 | 0.000298 |
East Asian | 0.000707 | 0.000707 |
Finnish | 0.0000464 | 0.0000462 |
European (Non-Finnish) | 0.000266 | 0.000264 |
Middle Eastern | 0.000707 | 0.000707 |
South Asian | 0.0000996 | 0.0000980 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Regulatory subunit of the IKK complex. Probably recruits IkappaBalpha/NFKBIA to the complex. May be involved in the organization of the cytomatrix at the nerve terminals active zone (CAZ) which regulates neurotransmitter release. May be involved in vesicle trafficking at the CAZ. May be involved in Rab-6 regulated endosomes to Golgi transport. {ECO:0000269|PubMed:15218148}.;
- Pathway
- NF-kappa B signaling pathway - Homo sapiens (human);Integrated Lung Cancer Pathway;Canonical NF-kappaB pathway;IL1-mediated signaling events
(Consensus)
Recessive Scores
- pRec
- 0.233
Intolerance Scores
- loftool
- 0.323
- rvis_EVS
- -0.88
- rvis_percentile_EVS
- 10.54
Haploinsufficiency Scores
- pHI
- 0.236
- hipred
- Y
- hipred_score
- 0.744
- ghis
- 0.578
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.610
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Erc1
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- regulation of transcription, DNA-templated;I-kappaB phosphorylation;multicellular organism development;protein transport;retrograde transport, endosome to Golgi;negative regulation of apoptotic process;positive regulation of NF-kappaB transcription factor activity
- Cellular component
- Golgi membrane;cytoplasm;IkappaB kinase complex;presynaptic membrane;synapse;presynaptic active zone
- Molecular function
- protein binding;Rab GTPase binding;PDZ domain binding;leucine zipper domain binding;cadherin binding